Rubella

Progress Toward Rubella Elimination and CRS Prevention in Europe

8 - 10 February 2012

Rubella during pregnancy often results in severe congenital abnormalities. Fortunately, the rubella vaccine has successfully eliminated rubella from the entire Western Hemisphere and Scandinavia. However, rubella continues to occur in much of Europe, in Asia and in Africa, and the WHO estimates that over 100,000 infants are born each year with congenital rubella syndrome. The Sabin Vaccine Institute, together with the March of Dimes, the World Health Organization (WHO) and the United States Centers for Disease Control and Prevention (CDC), is undertaking a series of advocacy activities to promote vaccination against rubella throughout the world.

• Read more

Vaccine Information Session

14 - 15 April 2011

The Sabin Vaccine Institute in partnership with Universidad Peruana Cayetano Heredia convened the Vaccine Information Session in Lima, Peru on April 14 – 15, 2011. The two day meeting was organized for journalists currently reporting on Global Health and attracted 30 journalists from 17 countries in the Region of the Americas.

• Read more

Sabin Receives $2 Million Grant to Lead Global Effort to Reduce Rubella and Congenital Rubella Syndrome (CRS) Burden through Vaccination

October 5, 2010

The Sabin Vaccine Institute (Sabin) today announced a major initiative which will encompass education and awareness activities for the prevention and control of rubella and congenital rubella syndrome (CRS).

While rubella itself is a disease that often causes only mild illness, a significant burden of the disease is associated with rubella virus infection during the first trimester of pregnancy. Known as congenital rubella syndrome, CRS causes significant hearing and visual impairment and mental retardation in countries where rubella infection is not yet controlled or eliminated.

• Read more